Clearance Summary
CALCITONIN 125 received FDA 510(k) clearance under submission number K781909, sponsored by Cambridge Nuclear Radiopharmaceutical. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 1979-01-10.
- Submission: K781909
- Applicant / Sponsor: Cambridge Nuclear Radiopharmaceutical
- Clearance pathway: Traditional
- Review panel: Clinical Chemistry
- Device class: Class II
- Regulation citation: 21 CFR 862.1140
- Decision date: 1979-01-10
Classification & Regulation
This clearance is catalogued under FDA product code JKR and 21 CFR 862.1140, within the Clinical Chemistry review panel as a Class II device.